Table 2.
Parameters | Experimental groups | ||||
---|---|---|---|---|---|
NDC | ND+ TVL | DC | D+TVL | D+Metformin | |
SOD (% inhibition) | 82.37±5.43 | 77.16±4.84 | 52.90±5.69**$ | 82.07±1.69# | 80.48±1.68# |
TBARS (nmol) | 219.60±0.015 | 205.10±0.009 | 314.10± 0.008***### | 211.50±0.008# | 212.60±0.015## |
NO (uM) | 27.35±1.85 | 28.39±0.83 | 18.86±1.42**$ | 28.61±1.72# | 26.80±2.97 |
Serum urea (mmol/L) | 4.94±0.21 | 5.33±0.26 | 26.70±2.13***$$$ | 11.67±1.65*### | 18.57±2.43***$$$# |
Serum creatinine (mmol/L) | 37.00±0.63 | 37.33±0.88 | 34.33±0.67 | 32.33±5.18 | 34.67±1.20 |
Significantly different from non-diabetic control, p<0.05.
Significantly different from non-diabetic control, p<0.01
Significantly different from non-diabetic control, p<0.001.
Significantly different from non-diabetic+TVL, p<0.05.
Significantly different from non-diabetic+TVL, p<0.001.
Significantly different from diabetic control, p<0.05
Significantly different from diabetic control, p<0.01.
Significantly different from diabetic control, p<0.001.